Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Role of Alpha Blocker Therapy
Author(s) -
Shaun Wen Huey Lee,
Men Long Liong,
Kah Hay Yuen,
Yee Vonne Liong,
John N. Krieger
Publication year - 2007
Publication title -
urologia internationalis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 53
eISSN - 1423-0399
pISSN - 0042-1138
DOI - 10.1159/000098064
Subject(s) - medicine , doxazosin , tamsulosin , terazosin , alfuzosin , prostatitis , placebo , chronic prostatitis/chronic pelvic pain syndrome , clinical trial , urology , lower urinary tract symptoms , prostate , blood pressure , alternative medicine , pathology , cancer , hyperplasia
This article reviews the rationale and data supporting alpha blocker therapy for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), the most common and difficult prostatitis syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom